HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Finance In Brief

This article was originally published in The Rose Sheet

Executive Summary

Revlon: Beauty company will record $10 mil. charge in FY 2006 relating to costs associated with organizational realignment in its sales, marketing and creative groups, firm announces Feb. 1. Initiative is expected to contribute $15 mil. in annual savings, Revlon notes. Realignment will "further our progress by enabling us to capitalize on marketplace opportunities in an even more effective and efficient manner, while furthering our objective to achieve long-term, profitable growth," according to Revlon CEO Jack Stahl. Company anticipates 2005 net sales to be up slightly to $1.33 bil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel